Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
EQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
EQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
EQS-Adhoc: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
EQS-Adhoc: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed
EQS-Adhoc: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed
EQS-News: STRATEC ANNUAL GENERAL MEETING ADOPTS RESOLUTION ON DIVIDEND AND APPROVES ALL AGENDA ITEMS: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
EQS-News: STRATEC ANNUAL GENERAL MEETING ADOPTS RESOLUTION ON DIVIDEND AND APPROVES ALL AGENDA ITEMS
EQS-News: STRATEC ANNUAL GENERAL MEETING ADOPTS RESOLUTION ON DIVIDEND AND APPROVES ALL AGENDA ITEMS
These Dividend Stocks Are an Investor's Best Friend: https://g.foolcdn.com/editorial/images/777461/dividends.jpg
These Dividend Stocks Are an Investor's Best Friend

Dividend stocks tend to struggle in high-interest-rate environments. The core reason is investors have an abundance of low-risk, high-yield income options when interest rates spike.

Conversely, fund

EQS-News: Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA
EQS-News: Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA
QuidelOrtho Opens New Distribution Center in Pedricktown, NJ: https://mms.businesswire.com/media/20240515422932/en/2132471/5/16x9_ribbon_cutting_2024.jpg
QuidelOrtho Opens New Distribution Center in Pedricktown, NJ


QuidelOrtho Corporation (Nasdaq: QDEL) has launched a second state-of-the-art United States distribution center in Pedricktown, New Jersey. This strategic endeavor epitomizes QuidelOrtho’s

Humana Ranks 6th Overall in Fair360 National Companies for Diversity: https://mms.businesswire.com/media/20240515913910/en/2130871/5/MicrosoftTeams-image_1.jpg
Humana Ranks 6th Overall in Fair360 National Companies for Diversity


Humana Inc. (NYSE: HUM) has ascended to No. 6 on Fair360’s prestigious list of the Top 50 Companies for Workplace Fairness, marking its seventh consecutive year in the top rankings. This

2 Reasons Amazon Stock Is a Buy and Hold Forever: https://g.foolcdn.com/editorial/images/775785/gettyimages-1131198259.jpg
2 Reasons Amazon Stock Is a Buy and Hold Forever

Amazon (NASDAQ: AMZN) is one of the largest companies on earth. For much of the world, especially the U.S., it's difficult to go a day without seeing one of the company's drivers making a delivery

EQS-News: Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification
EQS-News: Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification
EQS-News: Drägerwerk AG & Co. KGaA: Dräger annual shareholders’ meeting approves significant dividend increase: https://assets2.sharewise.com/attachment/file/24054/375px-Dr%C3%A4ger_Logo.svg.png
EQS-News: Drägerwerk AG & Co. KGaA: Dräger annual shareholders’ meeting approves significant dividend increase
EQS-News: Drägerwerk AG & Co. KGaA: Dräger annual shareholders’ meeting approves significant dividend increase
EQS-News: RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23735/Rhoen-klinikum.svg.png
EQS-News: RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter
EQS-News: RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter
EQS-News: Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effectshttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
EQS-News: Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
Geisinger and Acadia Healthcare Hold Groundbreaking Ceremony for New Behavioral Health Hospital in Danville: https://mms.businesswire.com/media/20240506592018/en/2123321/5/Acadia_GB5775_photo.jpg
Geisinger and Acadia Healthcare Hold Groundbreaking Ceremony for New Behavioral Health Hospital in Danville


Geisinger and Acadia Healthcare Company held a ceremony today to celebrate the start of construction on its previously announced state-of-the-art, 96-bed behavioral health hospital in Danville

EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24693/Fresenius.svg.png
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024
Why Rivian Shares Popped Friday: https://g.foolcdn.com/editorial/images/775713/rivian-truck-in-front-of-building-with-_rivian-logo_rivian.jpg
Why Rivian Shares Popped Friday

Rivian Automotive (NASDAQ: RIVN) stock popped Friday morning after the company reported that it has received a large incentive package from the state of Illinois to expand its electric vehicle (EV)

Cigna Group (CI) Q1 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Cigna Group (CI) Q1 2024 Earnings Call Transcript

Image source: The Motley Fool.

Cigna Group (NYSE: CI)Q1 2024 Earnings CallMay 02, 2024, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer: https://mms.businesswire.com/media/20240502548327/en/2116842/5/24Blaser.jpg
QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer


QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point of care settings, clinical labs and

AEVIS VICTORIA SA – Revenues from operating divisions are increasing, with positive forecasts for the current year. Growth for 1Q2024 is 7.2%.http://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA – Revenues from operating divisions are increasing, with positive forecasts for the current year. Growth for 1Q2024 is 7.2%.
AEVIS VICTORIA SA – Revenues from operating divisions are increasing, with positive forecasts for the current year. Growth for 1Q2024 is 7.2%.
Padraig McDonnell Assumes Agilent CEO Role: https://mms.businesswire.com/media/20240501393789/en/2115570/5/FULL-RES-PR-ceo-padraig-mcdonnell-1.jpg
Padraig McDonnell Assumes Agilent CEO Role


Agilent Technologies Inc. (NYSE:A) today announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately. His appointment is part of the company’s CEO transition plan

STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel: https://mms.businesswire.com/media/20240501408389/en/2115844/5/nate_sisitsky_linkedin.jpg
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today

EQS-News: Gerresheimer partners with RxCap to offer connected adherence solutions: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
EQS-News: Gerresheimer partners with RxCap to offer connected adherence solutions
EQS-News: Gerresheimer partners with RxCap to offer connected adherence solutions
Forget Nvidia, These Unstoppable Stocks Are Better Buys: https://g.foolcdn.com/editorial/images/773650/a-couple-meeting-with-an-advisor.jpg
Forget Nvidia, These Unstoppable Stocks Are Better Buys

Nvidia has been an amazing stock to own over the past few years, generating incredible returns for investors. But the risk is that expectations may be too high for the stock, especially with respect

This Healthcare Stock Just Gave Investors 100 Billion Reasons to Buy It: https://g.foolcdn.com/editorial/images/773165/person-giving-the-thumbs-up-after-receiving-a-vaccination-shot.jpg
This Healthcare Stock Just Gave Investors 100 Billion Reasons to Buy It

It's still early days in this latest earnings season, but it seems we can already tag one winner in the healthcare sector -- take a bow, UnitedHealth Group (NYSE: UNH).

As the season lurched into

Centene (CNC) Q1 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Centene (CNC) Q1 2024 Earnings Call Transcript

Image source: The Motley Fool.

Centene (NYSE: CNC)Q1 2024 Earnings CallApr 26, 2024, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Why ResMed Stock Is Soaring Today: https://g.foolcdn.com/editorial/images/774544/cpap-mask-person.jpg
Why ResMed Stock Is Soaring Today

Shares of ResMed (NYSE: RMD) had soared 16.2% higher as of 11:50 a.m. ET on Friday. The big jump came after the healthcare technology company reported results on Thursday evening for its fiscal 2024